Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids (NCT02577055) | Clinical Trial Compass
CompletedNot Applicable
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids
France9 participantsStarted 2016-04
Plain-language summary
Purpose of this study:
To establish the superiority of myomectomy versus Uterine Artery Embolization, in women with multiple symptomatic fibroids and no other infertility factor, seeking to conceive.
Who can participate
Age range18 Years – 43 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women aged ≥ 18 and ≤ 43 years old
* At least one interstitial fibroid more than 3 cm on MRIat MRI)
* with symptoms: genital bleeding, chronic pelvic pain or heaviness, anemia, or infertility \> 1 year.
* With immediate desire to conceive
* without assisted reproductive indication: no tubal infertility, menstrual irregularities, hydrosalpinx, endometriosis, adenomyosis, or male infertility.
* Patient with health insurance, who can read and understand French and who has given written consent
Exclusion Criteria:
* Ongoing regnancy
* Emergency Situation
* Contraindication to surgery or uterine embolization: allergy to contrast medium , renal failure, immunodeficiency, contraindication to anesthesia, subserosal or submucosal pedunculated fibroids, fibroids with largest diameter inside of the uterine cavity
What they're measuring
1
Number of live birth in a year of fertility attempt